BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Recordati S.p.A 

Via M. Civitali, 1

Milan    20148  Italy
Phone: 39-02-487871 Fax: 39-02-40073747


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Forest Laboratories, Inc.  Licensing agreement for the development of lercanidipine, a long-acting dihydropyridine calcium channel blocker for the treatment of hypertension.

Digital Gene Technologies  Atherosclerosis





 Company News
Recordati S.p.A: Shareholders Approve The 2013 Accounts. Dividend EU 0.33 Per Share 4/17/2014 9:43:43 AM    More...
Gebro Pharma Signs A Licensing Agreement With Recordati S.p.A For The Commercialization Of Kentera® In Spain 2/27/2014 8:48:10 AM    More...
Recordati S.p.A : Preliminary 2013 Results Show Significant Growth. Sales +13.7%, Ebit +17.0%, Net Income +12.8%. 2/11/2014 9:21:02 AM    More...
Apricus Biosciences (APRI), Recordati S.p.A Forge Erectile Dysfunction Pact Worth $47 Million 2/10/2014 7:13:04 AM    More...
Recordati S.p.A Board Of Directors Approves 2014 Objectives 1/16/2014 9:06:08 AM    More...
Recordati S.p.A Buys Tunisia's Opalia Pharma for 37 Million Euros 7/25/2013 6:35:59 AM    More...
Recordati S.p.A: Significant Sales and Earnings Growth in the First Quarter 2013 5/9/2013 11:05:51 AM    More...
Recordati S.p.A: Shareholders Approve the 2012 Accounts. Dividend EUR 0.30 Per Share 4/17/2013 10:54:37 AM    More...
Recordati S.p.A: Board Approves the 2012 Accounts 3/7/2013 9:55:15 AM    More...
Recordati S.p.A: Positive Preliminary 2012 Results. Sales +8.7%, EBIT +2.1%, Net Income +1.8% 2/13/2013 9:58:01 AM    More...
12345678910...

//-->